Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Asset Utilization Ratio: 2010-2025

Historic Asset Utilization Ratio for Aytu Biopharma (AYTU) over the last 16 years, with Jun 2025 value amounting to 0.55.

  • Aytu Biopharma's Asset Utilization Ratio fell 6.47% to 0.51 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.51, marking a year-over-year decrease of 6.47%. This contributed to the annual value of 0.55 for FY2025, which is 7.00% up from last year.
  • As of FY2025, Aytu Biopharma's Asset Utilization Ratio stood at 0.55, which was up 7.00% from 0.51 recorded in FY2024.
  • Aytu Biopharma's Asset Utilization Ratio's 5-year high stood at 0.78 during FY2023, with a 5-year trough of 0.31 in FY2021.
  • In the last 3 years, Aytu Biopharma's Asset Utilization Ratio had a median value of 0.55 in 2025 and averaged 0.61.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first skyrocketed by 63.47% in 2023, then plummeted by 34.65% in 2024.
  • Over the past 5 years, Aytu Biopharma's Asset Utilization Ratio (MRY) stood at 0.31 in 2021, then soared by 53.01% to 0.48 in 2022, then soared by 63.47% to 0.78 in 2023, then crashed by 34.65% to 0.51 in 2024, then increased by 7.00% to 0.55 in 2025.
  • Its Asset Utilization Ratio was 0.55 in FY2025, compared to 0.51 in FY2024 and 0.78 in FY2023.